GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TaiRx Inc (ROCO:6580) » Definitions » Research & Development

TaiRx (ROCO:6580) Research & Development : NT$146.28 Mil (TTM As of Jun. 2024)


View and export this data going back to 2017. Start your Free Trial

What is TaiRx Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. TaiRx's Research & Development for the six months ended in Jun. 2024 was NT$53.37 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2024 was NT$146.28 Mil.


TaiRx Research & Development Historical Data

The historical data trend for TaiRx's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TaiRx Research & Development Chart

TaiRx Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only 178.83 118.73 84.46 168.46 173.08

TaiRx Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 79.90 88.56 80.17 92.91 53.37

TaiRx Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$146.28 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TaiRx  (ROCO:6580) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


TaiRx Research & Development Related Terms

Thank you for viewing the detailed overview of TaiRx's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


TaiRx Business Description

Traded in Other Exchanges
N/A
Address
No. 66, Sanchong Road, 1st Floor, 6th Floor, Nangang District, Taipei, TWN, 11502
TaiRx Inc is a pharmaceutical company based in Taiwan. It develops new drugs and improves current standard treatments to promptly find cures for diseases and fulfill unmet medical needs. The company focuses on new drug development for Asia and other markets.

TaiRx Headlines

No Headlines